Inhalation Capsules Market 2024 – Market Size & Segments Analysis, Industry Trends, Manufacturers Analysis, Opportunities and Forecast 2030

The global market value of Inhalation capsules market was valued at USD 850.4 million in 2022, and CAGR of 6.8% is expected during the forecast period. In order to increase the demand for directly deliver the drug to the respiratory system is driving growth in the market significantly. These capsules are known as dry powder inhaler, and is expected to treat various respiratory disorders. Ease of use, portability, and quick remedy are the features Inhalation capsules possess. Increasing demand to treat asthma, chronic obstructive pulmonary diseases, and other respiratory problems are driving growth in the market significantly.

One of the key advantages of Inhalation capsules market is their quick action unlike the oral medicines. Oral medicine needs to pass through digestive system first. Increasing demand for inhalation capsules is required, where speedy reaction is required. Inhalation capsules are needed for pediatric patients, and geriatric population.

Impact of Covid-19

Covid-19 has had a significant impact on Inhalation Capsules Market. Pandemic increased the number of respiratory patients, the demand for inhalation therapies increased to manage respiratory symptoms associated with the virus, disruptions in the pharmaceutical supply chain, and restrictions in healthcare services have affected the market’s growth. Shift in healthcare priorities and budget allocations during the pandemic have influenced the adoption of inhalation capsules. Increasing demand for inhalation capsules to treat various breathing disorders is driving growth in the market. Speedy recovery is needed in modern era in case of every disease, and inhalation capsules are required to react quickly, and thus it is beneficial for kids, and geriatric population.

Growth Drivers

Increasing demand for the medicines, which is used in inhalation therapies like dry powder inhalers, and metered dose inhalers. These capsules deliver medication directly to lungs, making them effective for treating respiratory conditions like asthma, COPD, and other respiratory diseases. With rising prevalence of respiratory diseases such as asthma, cystic fibrosis, and COPD, there is a growing need for effective inhalation therapies.

Advancement in inhalation technologies, including the development of more efficient delivery devices and formulations, are enhancing the effectiveness, and convenience of inhalation therapies. Aging population is more susceptible to respiratory diseases, leading to increased demand for respiratory medicines. Inhalation therapies offer several advantages over other routes of administration, such as rapid onset of action, targeted delivery to the lungs, and reduced systematic side effects.

Inhalation capsules are being developed for a broader range of respiratory conditions, as well as for non-respiratory issues. Favorable regulatory initiatives, and guidelines aimed at streamlining the approval process for inhalation medications and ensuring their safety and efficacy further stimulates the market growth. Increasing demand for kids, and geriatric population is driving growth in the market significantly. Growing number of patients suffering from lungs disease is driving the demand for inhalation capsules in order to get rid off various diseases.

Segmentation

By Type

·         Gelatin Capsules

·         Hypromellose Capsules                                          

By Application

·         Asthma

·         COPD

·         Others

Regional Outlook

·         Asia Pacific

·         North America

·         Latin America

·         Europe

·         Middle East and Africa

Inhalation Capsules Market by Type Segmentation

On the basis of type, the inhalation capsule market is segmented into gelatin capsules and Hypromellose capsules. Gelatin capsules are the leading segment and are expected to dominate the market during the forecast period due to their widespread use, compatibility with a variety of medications, and established safety profile.

Gelatin capsules offer advantages such as easy handling, reliable sealing, and effective protection of the medication within. Gelatin capsules are customized in terms of size, shape, and color, making them suitable for various inhalation devices and patient preferences. Hypromellose capsules are an alternative to gelatin capsules in the inhalation capsule market. It provides suitability for vegetarian customers.

It provides a barrier to moisture and has low oxygen permeability, which do help in maintaining the stability and efficacy of medication inside. With a growing vegan population worldwide, the demand for Hypromellose capsules in the entire world is increasing. These capsules are beneficial for all pulmonary diseases, like asthma, COPD, and pneumonia.

Inhalation Capsules Market by Application Segmentation

On the basis of the application, the inhalation capsule market is segmented into asthma, COPD, and others. Asthma is the leading segment in the inhalation capsule market due to its prevalence worldwide and the need for effective and convenient treatment. Inhalation capsules offer a targeted and efficient delivery method for asthma medications, allowing for quick relief of symptoms and improved patient adherence. Increasing pollution caused by the rising number of vehicles on the road is the main reason for all breathing issues. Increasing demand for inhalation capsules for the geriatric population is driving growth in the market significantly. Asthma patients all over the world are preferring inhalation capsules, which is driving growth in the market. The rapidly increasing population all over the world is driving growth in the market.

Regional Outlook

On the basis of the regions, the inhalation capsule market is segmented into 5 parts: Asia Pacific, North America, Latin America, Europe, and the Middle East and Africa. Due to advanced healthcare infrastructure, ongoing research and developments are responsible for market growth. The Asia-Pacific region, due to its rapidly increasing population and increasing disposable income, is inspiring people to go for various available treatment options.

Increasing respiratory diseases, a growing number of vehicles causing pollution, and smoke, which results in respiratory diseases, are inspiring the market in the region. Japan, China, and India are key markets in the region, with a focus on innovative drug delivery systems and the development of generic inhalation drugs to cater to a large group of patients. The aging population in European countries is disease-prone, and they are suffering from various breathing issues like asthma, COPD, and pneumonia.

The market is influenced by factors such as technological advancements in inhalation devices, the increasing prevalence of respiratory diseases, and the growing demand for convenient drug delivery methods. The Middle East, Africa, and Latin America are witnessing moderate growth due to several factors. Increasing health awareness in the region is driving the demand for inhalation capsules on the market.

Key Players

·         Elpen S.A.

·         Qualicaps

·         Capsugel

·         ACG Worldwide

·         Boehringer Ingelheim GmbH

·         Novartis

·         Pfizer

·         Astrazeneca

·         Cipla

·         Vectura Group

·         Other Players